Novartis To Buy Breast Cancer Therapy For Up To $3B
By Najiyya Budaly ( March 20, 2026, 11:52 AM GMT) -- Novartis AG said Friday that it will acquire a breast cancer drug from U.S. developer Synnovation Therapeutics in a deal worth up to $3 billion as it seeks to strengthen its oncology treatment pipeline....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.